BOSTON SCIENTIFIC CORP·4

Feb 23, 4:18 PM ET

Pierce David A 4

4 · BOSTON SCIENTIFIC CORP · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-21
Pierce David A
SVP and President, Endoscopy
Transactions
  • Exercise/Conversion

    Common Stock

    2022-02-21+2,4934,377 total
  • Exercise/Conversion

    Deferred Stock Units

    2022-02-212,4932,493 total
    Exp: 2023-02-21Common Stock (2,493 underlying)
  • Tax Payment

    Common Stock

    2022-02-21$42.55/sh732$31,1473,645 total
Footnotes (2)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary